SARS-CoV-2 (COVID-19) Testing Service

UKAS accredited service laboratory for processing COVID-19 tests

Viral RNA extraction, qRT-PCR and rapid whole genome sequencing workflows for detection of all known variants of SARS-CoV-2

A complete SARS-CoV-2 testing workflow from RNA extraction through to qRT-PCR and rapid viral whole genome sequencing (WGS) to support testing laboratories.

Our high throughput service facility can perform up to 5000 qRT-PCR COVID-19 tests per day ensuring test results are delivered quickly and efficiently.

If you are looking for a high throughput UK laboratory to process your SARS-CoV-2 (COVID-19) tests, we can help.

Service Capabilities

Informed Genomics mission

Viral RNA extraction service

Our viral RNA extraction service isolates viral RNA from nasopharyngeal swabs or other biofluids. We use a magnetic bead-based technology which is ideally suited to high through-put processing and enables us to carry out extractions at scale. The purification of high-quality RNA free from protein and other impurities is required for downstream qRT-PCR or rapid viral whole genome sequencing (WGS).

Find out more about VirPath RNA extraction kit for COVID-19 testing laboratories.

SARS-CoV-2 multiplex qRT-PCR service

Our SARS-CoV-2 qRT-PCR service uses VirPath SARS-CoV-2 Multiplex qRT-PCR Kit. This kit is CE-IVD marked and is one of the few COVID-19 qRT-PCR tests to pass the stringent accuracy and sensitivity requirements set for Fit to Fly, Day 2 testing and general COVID-19 testing.


Detects all known variants


CE-IVD marked


Approved for Day 2 testing

Find out more about VirPath Multiplex qRT-PCR kit for COVID-19 testing laboratories.


SARS-CoV-2 whole genome sequencing

We have over 6 years of experience in developing and manufacturing sequencing products and delivering sequencing services for diagnostic testing. In May 2020 our sister company, Nonacus was funded by the UK Government (Innovate UK) to develop a novel rapid method for whole genome sequencing for viral surveillance which means we are well placed to offer customers this as a service.

SARS-CoV-2 WGS service

Our WGS service uses a robust and rapid method for whole genome sequencing of the SARS-CoV-2 virus that is ideally suited for Day 2 testing and will deliver data that meet the required standards:


All samples with cycle threshold (CT) values of <30 (defined as equivalent to ~10,000-1,000 viral genome copies/ml) will be sequenced.

Coverage guarantees:
All SARS-CoV-2 genomes will have a minimum sequencing coverage of 50% at >= 30x coverage.
For samples with a CT <20, (defined as viral genome copy number equivalent of <1,000,000 viral genome copies per ml,) 95% of samples should have a reference genome coverage breadth of >97% at >=30x coverage.
For CT above 20, defined as viral genome copy number equivalent of >1,000 per ml, 95% of samples should have a reference genome coverage breadth of >75% at >=30x coverage.

Contact Us

+44 121 415 8543

Birmingham Research Park, 97 Vincent Drive, Birmingham